A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial to be presented June 5 at the annual meeting of ...
Jun 5, 2016
In the first-ever clinical trial for metastatic patients previously treated for the disease, research led by The University of Texas MD Anderson Cancer Center found that the immune checkpoint blockade nivolumab shows promise ...
Jun 5, 2016
The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug's target, according to ...
Jun 5, 2016
In an intensive care unit, a nurse soothes a crying baby rescued in a raid on a private Indian hospital that police suspect was selling abandoned newborns on the black market.
Jun 5, 2016
